BIIB033 In Acute Optic Neuritis (AON)
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects
|4||Enrolling by invitation||
Long-Term Assessment of Remyelinating Therapy
Safety Study of BIIB033 in Subjects With Multiple Sclerosis
† Study has passed its completion date and status has not been verified in more than two years.